ZEPP — Zepp Health Income Statement
0.000.00%
Last trade - 00:00- $50.91m
- $101.47m
- CNY2.50bn
- 64
- 90
- 28
- 63
Annual income statement for Zepp Health, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,812 | 6,433 | 6,250 | 4,143 | 2,495 |
| Cost of Revenue | |||||
| Gross Profit | 1,468 | 1,333 | 1,306 | 803 | 658 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 5,208 | 6,203 | 6,156 | 4,567 | 2,705 |
| Operating Profit | 604 | 231 | 93.9 | -424 | -209 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 652 | 266 | 107 | -373 | -237 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 574 | 234 | 95.9 | -307 | -221 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 575 | 229 | 138 | -288 | -212 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 573 | 229 | 138 | -288 | -212 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.25 | 0.687 | 0.521 | -1.13 | -0.866 |